Clinical Trial Update: A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating first-line treatment of small cell lung cancer using adebrelimab and vunakizumab in combination with chemotherapy; the study is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Vunakizumab (Vunakizumab)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Vunakizumab, Adebrelimab | Phase 2 | Status: NOT_YET_RECRUITING